Aripiprazole augmentation, antidepressant combination or switching therapy in patients with major depressive disorder who are partial-or non-responsive to current …

C Han, SM Wang, HJ Seo, BC Lee, HJ Jeon… - Journal of psychiatric …, 2014 - Elsevier
switched therapyaugmentation with aripiprazole may be more clinically beneficial compared
to antidepressant combination, and at least equally beneficial to antidepressant switching

Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: a 6-week, randomized, rater-blinded, prospective study

C Han, SM Wang, KP Kwak, WY Won, HY Lee… - Journal of psychiatric …, 2015 - Elsevier
… Likewise, our study utilized two different treatment strategies, aripiprazole augmentation and
antidepressant switch using diverse antidepressants. Hence, it should not be easy to apply …

[PDF][PDF] Optimizing the use of aripiprazole augmentation in the treatment of major depressive disorder: from clinical trials to clinical practice

C Han, SM Wang, SJ Lee, TY Jun… - Chonnam medical …, 2015 - synapse.koreamed.org
… only for partial responders and switching therapy for minimal or nonresponders should
be revised, because aripiprazole augmentation may give a direct benefit and a more rapid …

Real-world effectiveness and safety of aripiprazole augmentation therapy in patients with major depressive disorder

K Kamijima, M Yasuda, K Yamamura… - … medical research and …, 2018 - Taylor & Francis
… In a naturalistic setting, patients showed a clear preference for aripiprazole augmentation
therapy over an antidepressant combination or switching to a different antidepressant and, …

Comparing Cost-Effectiveness of Aripiprazole Augmentation With Other" Next-Step" Depression Treatment Strategies: A Randomized Clinical Trial

J Yoon, S Zisook, A Park, GR Johnson… - The Journal of …, 2018 - legacy.psychiatrist.com
… The ICER for the aripiprazole augmentation versus switching … for aripiprazole augmentation
versus bupropion augmentation … and social adjustment outcomes between treatment groups. …

Efficacy and safety of aripiprazole or bupropion augmentation and switching in patients with treatment-resistant depression or major depressive disorder: A systematic …

M Ji, J Feng, G Liu - Plos one, 2024 - journals.plos.org
… we could not confirm whether longer switching or augmentation treatment would have
different efficacy or risks. Fourthly, only bupropion and Aripiprazole were evaluated in this meta-…

Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia

CS Wisniewski, S Robert - Annals of Pharmacotherapy, 2012 - journals.sagepub.com
… The authors concluded that all 3 strategies were equally effective for switching therapy to
aripiprazole in patients on established antipsychotic monotherapy. While this study included a …

If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies

KR Connolly, ME Thase - Drugs, 2011 - Springer
therapy, with half receiving active aripiprazole and half receiving a second course of placebo.
Aripiprazole … , demonstrating significant benefits for active aripiprazole (average dose ∼10 …

Current evidence for aripiprazole as augmentation therapy in major depressive disorder

A Khan - Expert Review of Neurotherapeutics, 2008 - Taylor & Francis
treatment strategies, either switching or other augmentation. … duration of augmentation with
aripiprazole for the treatment-… Second, there is a need to determine whether aripiprazole is …

[HTML][HTML] The potential utility of aripiprazole augmentation for major depressive disorder with mixed features specifier: a retrospective study

C Han, SM Wang, WM Bahk, SJ Lee… - Clinical …, 2019 - ncbi.nlm.nih.gov
… observe potential benefit of aripiprazole augmentation in the treatment of major depressive
… The MADRS total score change was approximately 7 point which is comparable with those (…